Morin Inhibits Proliferation, Migration, and Invasion of Bladder Cancer EJ Cells via Modulation of Signaling Pathways, Cell Cycle Regulators, and Transcription Factor‐Mediated MMP‐9 Expression
Authors:
- 8 February 2017
- journal article
- research article
- Published by Wiley in Drug Development Research
- Vol. 78 (2) , 81-90
Abstract
Preclinical Research Previous studies have shown that morin exerts diverse pharmacological activities. In this study, we investigated the inhibitory activity of morin on bladder cancer EJ cells. Morin significantly inhibited EJ cell proliferation, which was related to the G1‐phase cell cycle arrest together with the reduced expression of cyclin D1, cyclin E, CDK2, and CDK4 via increased expression of p21WAF1. Morin also increased ERK1/2 phosphorylation and decreased JNK and AKT phosphorylation without altering the p38MAPK phosphorylation levels. Morin treatment suppressed the migration and invasion of EJ cells in wound‐healing and transwell cell invasion assays. Zymographic and electrophoretic mobility shift assays showed that morin suppressed the expression of matrix metalloproteinase‐9 (MMP‐9) via repression of the binding activity of AP‐1, Sp‐1, and NF‐κB. Collectively, these results demonstrate that morin reduced cyclin D1, cyclin E, CDK2 and CDK4 expression via the induction of p21WAF1 expression, increased ERK1/2 phosphorylation and decreased JNK, and AKT phosphorylation, and prevented MMP‐9 expression via the inhibition of transcription factors AP‐1, Sp‐1, and NF‐κB, thereby resulting in the inhibition of growth, migration, and invasion of bladder cancer EJ cells. These results provide a novel insight into the use of morin in the prevention of bladder cancer. Drug Dev Res 78 : 81–90, 2017.Keywords
This publication has 25 references indexed in Scilit:
- Interleukin-20 Promotes Migration of Bladder Cancer Cells through Extracellular Signal-regulated Kinase (ERK)-mediated MMP-9 Protein Expression Leading to Nuclear Factor (NF-κB) Activation by Inducing the Up-regulation of p21WAF1 Protein Expression *Journal of Biological Chemistry, 2013
- Rb inactivation in cell cycle and cancer: The puzzle of highly regulated activating phosphorylation of CDK4 versus constitutively active CDK-activating kinaseCell Cycle, 2010
- Matrix Metalloproteinase-9 Functions as a Tumor Suppressor in Colitis-Associated CancerCancer Research, 2010
- Morin regulates the expression of NF-κB-p65, COX-2 and matrix metalloproteinases in diethylnitrosamine induced rat hepatocellular carcinomaChemico-Biological Interactions, 2009
- Cell signaling pathways altered by natural chemopreventive agentsMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2004
- The phosphatidylinositol 3-Kinase–AKT pathway in human cancerNature Reviews Cancer, 2002
- Synergistic upregulation of metalloproteinase‐9 by growth factors and inflammatory cytokines: an absolute requirement for transcription factor NF‐κBFEBS Letters, 1998
- Opposing Effects of ERK and JNK-p38 MAP Kinases on ApoptosisScience, 1995
- Transcriptional control by protein phosphorylation: signal transmission from the cell surface to the nucleusCurrent Biology, 1995
- How MAP Kinases Are RegulatedJournal of Biological Chemistry, 1995